California Attorney General Rob Bonta claims that 23andMe's recent bankruptcy sale of genetic data to TTAM Research Institute does not comply with state privacy laws, specifically the Genetic Information Privacy Act, and is considering further legal action despite court approval of the sale.
Anne Wojcicki is reclaiming control of 23andMe by purchasing its assets through TTAM Research Institute for $305 million after the company's bankruptcy, surpassing an earlier bid from Regeneron Pharmaceuticals, amid ongoing privacy and profitability challenges.
23andMe has agreed to sell its assets, including its genetic testing and research services, to TTAM Research Institute for $305 million, following a court-approved bidding process that included a backup bid from Regeneron. TTAM commits to maintaining privacy policies, enhancing consumer protections, and continuing scientific research, with the transaction subject to court approval scheduled for June 17, 2025.